← Open Payments lookup

MICHAEL WILL: Open Payments

NPI 1073876090 · PALM DESERT, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,101 in 55 payments from 18 companies in 2025. Trend: 2023 $1,513 · 2024 $1,245 · 2025 $1,101

Food & beverage: $1,101
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP12$281
Lilly USA, LLC8$152
GlaxoSmithKline, LLC.5$91
Boehringer Ingelheim Pharmaceuticals, Inc.3$73
Amgen Inc.4$69
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$61
Bayer Healthcare Pharmaceuticals Inc.3$56
Almatica Pharma LLC3$55
Novo Nordisk Inc3$54
Otsuka America Pharmaceutical, Inc.2$36

Products named: AIRSUPRA, MOUNJARO, TRELEGY ELLIPTA, FARXIGA, JARDIANCE, XIFAXAN, Kerendia, LOREEV XR.

Industry payments across CA — which companies pay providers there.